![[The Ross Report. By Robert Ross, Senior Vice President + Executive Director]](/images/rr-head3.gif)
April 29, 2003
ON THE MONUMENTAL IMPORTANCE OF EVERY DISEASE IN MDA’s
PROGRAM
MDA’s programs of research and health care services cover
a wide spectrum of neuromuscular diseases, more than 40 in all.
These disorders can be distinguished in a number of ways, from
age of onset to rapidity of progression, from region of the body
affected to the question of whether an obvious inheritance pattern
is present.
Certain of these diseases -- such as the spinal muscular atrophies,
Charcot-Marie-Tooth disease or the Duchenne and myotonic forms
of muscular dystrophy -- affect many thousands of Americans. Others
affect a smaller portion of the population but are no less serious
in their destructive effects on mobility, respiration and other
vital body processes.
I’m proud to say that MDA offers the same broad program
of health care services for all of the diseases we cover, regardless
of numbers affected. MDA’s network of 230 hospital-affiliated
clinics serves individuals with all of these diseases who are
registered with MDA, offering diagnostic and follow-up care, and
providing assistance with purchase of medically prescribed equipment,
including but not limited to wheelchairs and leg braces. Other
vital MDA-provided services that make life better for families
include MDA support groups, loan closets and MDA’s summer
camp program for children.
MDA’s research program targets all of these diseases, whether
through funding of disease-specific investigative studies or by
providing grants directed at broader neuromuscular research that
may yield insights into a variety of diseases. MDA-funded research
into such disorders as acid
maltase deficiency continues to make effective inroads in
the search for treatments and cures.
MDA’s award-winning magazine, Quest, offers in-depth scientific
articles on these disorders as well as lifestyle features of interest
to a broad cross-section of the families we serve.
From the Diseases
link on our comprehensive Web site, Internet users can find specially
designed pages for each of the diseases in our program. Each page
contains a plethora of links and information, providing an invaluable
gateway to medical and lifestyle resources for those affected
by these diseases. In the last several years, MDA has augmented
its online services program with a wide range of regularly scheduled
chat sessions
on topics ranging from recent research developments to employment
to parenting.
The Jerry Lewis MDA Telethon, too, has been a showcase for the
extreme variety of neuromuscular diseases and the people affected
by them, and in recent years has familiarized millions of viewers
in the United States, Puerto Rico and Canada with families and
individuals fighting CMT, Duchenne, limb-girdle and other forms
of muscular dystrophy, nemaline myopathy, spinal muscular atrophy,
amyotrophic lateral sclerosis and dermatomyositis.
One of our highest-profile Telethon personalities in the last
two years has been 12-year-old MDA National Goodwill Ambassador
Mattie Stepanek. Through
his appearances on our Telethon’s national broadcasts in
2001 and 2002, Mattie has helped educate millions of Americans
about his extremely rare disorder, dysautonomic
mitochondrial myopathy, which presents Mattie with numerous
daily challenges affecting his mobility, respiration and his ability
to metabolize food. What’s more, in his ambassador role
Mattie has appeared in behalf of MDA at public gatherings across
the country.
Although the number of people affected by Mattie’s disorder
is indeed small, one can't overstate the enormity of the disease’s
effect on a family such as his. Mattie’s mother, Jeni, has
an adult-onset form, a fact that was unknown to her until after
the birth of her four children, all of whom inherited the disorder.
Mattie’s three siblings died of the disease, and Mattie’s
life has been marked by frequent hospitalizations and several
close brushes with his own mortality.
From the perspective of a family like the Stepaneks, mitochondrial
myopathy can hardly be termed “rare.” It’s indeed
an immensely significant presence in their lives, one that affects
nearly every facet of their existence and must be reckoned with
constantly.
At MDA, we recognize that all of the diseases in our program
are of monumental importance, most especially to affected families.
This vital understanding will continue to inform and energize
our efforts as we strive to administer the finest in research
and services programs to make life better for these families.
With every best wish...
|